ASSESSMENT OF EFFICIENCY OF TREATMENT OF OVERACTIVE BLADDER IN ELDERLY PATIENTS
The effectiveness of overactive bladder treatment with M -cholinoblocker solifenacin (Vesicare) as monotherapy and in combination with α <sub>1</sub>-andrenoblocker terazosin (Setegis) or bladdrer training in elderly patients was evaluated. The results of 12 weeks treatment in all treatment modality groups were comparable. Use of solifenacin in combination with α <sub>1</sub>-andrenoblocker in comparison to solifenacin monotherapy resulted in longer symptoms remission.